Taro claims Sun's tender offer is a "sham"
This article was originally published in Scrip
Executive Summary
The board of Taro Pharmaceutical Industrieshas advised the company's shareholders to rejectSun Pharmaceutical Industries' recent tender offer, terming it as "financially inadequate" and a "sham".